SEC Filing Madrigal Pharmaceuticals.

SEC Filing NeuroBo Pharmaceuticals, Inc.

Deutsche Bank AG Purchases 6,840 Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL)

B. Riley Securities Downgrades Madrigal Pharmaceuticals (MDGL)

Breaking: FDA approves Madrigal's Rezdiffra as first MASH therapy - BioSpace

SEC Filing Kiniksa Pharmaceuticals

Madrigal Pharmaceuticals (MDGL) 10K Form and SEC Filings 2024

Madrigal Pharmaceuticals Inc - DEF 14A - Proxy Statement - May 01, 2023

Madrigal Pharmaceuticals launches $500 million stock offering By Investing.com

Quidel Corp Says Increased Size Of Board To Eight Members - SEC Filing